BRILINTA 90 mg/1
Ticagrelor · TABLET · AstraZeneca Pharmaceuticals LP
No Recall History
Plain English
BRILINTA is a tablet containing ticagrelor at 90 mg/1, taken oral. Manufactured by AstraZeneca Pharmaceuticals LP.
Key Facts
- Brand Name
- BRILINTA
- Generic Name
- Ticagrelor
- NDC Code (Product)
0186-0777- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Strength
- 90 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA022433
- Drug Class
- P2Y12 Platelet Inhibitor [EPC]
- Marketing Start
- 08/05/2011
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
dyspnoea3,977 reports
myocardial infarction2,760 reports
death1,720 reports
fatigue1,537 reports
off label use1,514 reports
chest pain1,458 reports
dizziness1,238 reports
contusion1,085 reports
drug interaction947 reports
asthenia913 reports
Frequently Asked Questions
What is BRILINTA used for?
BRILINTA contains Ticagrelor. It is a tablet taken oral. Consult your doctor for specific uses.
Is BRILINTA a controlled substance?
BRILINTA is not classified as a controlled substance by the DEA.
What is the generic name for BRILINTA?
The generic name for BRILINTA is Ticagrelor. There are 12 other brand versions of Ticagrelor.
What is the NDC code for BRILINTA 90 mg/1?
The NDC (National Drug Code) for BRILINTA 90 mg/1 is 0186-0777, listed by AstraZeneca Pharmaceuticals LP.